Harvard Net Income from 2010 to 2026
| HBIO Stock | USD 0.58 0.01 1.69% |
Net Loss | First Reported 2000-03-31 | Previous Quarter -2.3 M | Current Value -1.2 M | Quarterly Volatility 8.5 M |
Check Harvard Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harvard Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.7 M, Interest Expense of 3.9 M or Total Revenue of 97.1 M, as well as many indicators such as Price To Sales Ratio of 1.69, Dividend Yield of 0.0022 or PTB Ratio of 1.58. Harvard financial statements analysis is a perfect complement when working with Harvard Bioscience Valuation or Volatility modules.
Harvard | Net Income | Build AI portfolio with Harvard Stock |
Evaluating Harvard Bioscience's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Harvard Bioscience's fundamental strength.
Latest Harvard Bioscience's Net Income Growth Pattern
Below is the plot of the Net Income of Harvard Bioscience over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Harvard Bioscience financial statement analysis. It represents the amount of money remaining after all of Harvard Bioscience operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Harvard Bioscience's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harvard Bioscience's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (12.4 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Harvard Net Income Regression Statistics
| Arithmetic Mean | (5,107,895) | |
| Coefficient Of Variation | (130.01) | |
| Mean Deviation | 5,404,805 | |
| Median | (3,462,000) | |
| Standard Deviation | 6,640,802 | |
| Sample Variance | 44.1T | |
| Range | 22.9M | |
| R-Value | (0.62) | |
| Mean Square Error | 28.8T | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | (819,034) | |
| Total Sum of Squares | 705.6T |
Harvard Net Income History
Other Fundumenentals of Harvard Bioscience
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Harvard Bioscience Net Income component correlations
About Harvard Bioscience Financial Statements
Harvard Bioscience investors utilize fundamental indicators, such as Net Income, to predict how Harvard Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -14.3 M | -13.6 M | |
| Net Loss | -8.6 M | -8.1 M | |
| Net Loss | -11.2 M | -10.6 M | |
| Net Loss | (0.26) | (0.27) | |
| Net Income Per E B T | 0.96 | 0.49 |
Pair Trading with Harvard Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Harvard Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harvard Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with Harvard Stock
| 0.74 | GSS | Genetic Signatures Earnings Call This Week | PairCorr |
Moving against Harvard Stock
| 0.59 | OBD | Oxford Biodynamics PLC | PairCorr |
| 0.54 | PRTC | PureTech Health plc | PairCorr |
| 0.5 | TXG | 10X Genomics | PairCorr |
| 0.49 | MLAB | Mesa Laboratories | PairCorr |
| 0.45 | BPH | BPH Energy Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Harvard Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Harvard Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Harvard Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Harvard Bioscience to buy it.
The correlation of Harvard Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Harvard Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Harvard Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Harvard Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Harvard Bioscience Correlation against competitors. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Will Life Sciences Tools & Services sector continue expanding? Could Harvard diversify its offerings? Factors like these will boost the valuation of Harvard Bioscience. Market participants price Harvard higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Harvard Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.80) | Earnings Share (1.21) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
Harvard Bioscience's market price often diverges from its book value, the accounting figure shown on Harvard's balance sheet. Smart investors calculate Harvard Bioscience's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Harvard Bioscience's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.